Bufotalin sensitizes death receptor-induced apoptosis via Bid- and STAT1-dependent pathways

22Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

Abstract

Tumor necrosis factor-alpha (TNF-α) and TNF-related apoptosis-inducing ligand (TRAIL) are apoptosis-inducing ligands that stimulate death receptors. In this study, we investigated the effects of bufotalin, a major compound in toad venom, on sensitizing TNF-α and TRAIL-induced apoptosis of HeLa cells. Bufotalin promoted death receptor-mediated cell death, especially TRAIL-induced apoptosis, through activation of caspase-3 and PARP-1. Mitochondrial Bid-dependent pathway was activated in TNF-α-induced cell death. Cotreatment of bufotalin with TRAIL resulted in the downregulation of antiapoptotic proteins, including Bcl-XL, Mcl-1, survivin and XIAP, and the up-regulation of MAPKs and TRAIL receptor DR5. In addition, phosphorylation of STAT1 was strongly inhibited by bufotalin. Moreover, DR5 expression was induced by knocking down the STAT1 expression. Moreover, the TRAIL-induced apoptotic response was promoted by STAT1 siRNA. Our results demonstrated that bufotalin is a powerful sensitizer of death receptor-induced apoptosis in cancer cells.

Author supplied keywords

Cite

CITATION STYLE

APA

Waiwut, P., Inujima, A., Inoue, H., Saiki, I., & Sakurai, H. (2012). Bufotalin sensitizes death receptor-induced apoptosis via Bid- and STAT1-dependent pathways. International Journal of Oncology, 40(1), 203–208. https://doi.org/10.3892/ijo.2011.1182

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free